Literature DB >> 12479380

C-reactive protein as a biomarker of emergent osteoarthritis.

MaryFran Sowers1, Mary Jannausch, Evan Stein, David Jamadar, Marc Hochberg, Laurie Lachance.   

Abstract

OBJECTIVE: We evaluated C-reactive protein (C-RP), a quantitative marker of the acute phase response, as a potential biomarker of prevalent and incident osteoarthritis of the knee (OAK).
METHODS: Serum C-reactive protein concentrations were characterized with ultrasensitive rate nephelometry in a population-based sample of 1025 women (318 African-American and 707 Caucasian) who are enrollees in a study of musculoskeletal conditions at the mid-life. Assignment of OAK was based on Kellgren-Lawrence (K-L) scores of 2 or more on radiographs. Prevalent OAK was based on the baseline (1996) score while the classification of incident OAK was based on a score of 2 or greater at the follow-up examination 2.5 years later amongst those with a baseline K-L scores of 0 or 1.
RESULTS: At baseline, the prevalence of radiographic OAK was 12% in participants who were aged 27-53 years and 18% in the subgroup of women aged 40-53 years. The mean C-RP value was 2.31 mg/L, with values ranging from below detection (0.3 mg/L) to 47.4 mg/L. Higher C-RP concentrations were associated with both prevalent and incident OAK (P < 0.0001, and P < 0.0001, respectively). For each K-L score increase from 0 to 3, there was a significantly higher mean C-RP value. Compared to women without incident OAK, women who developed OAK in the 2.5-year follow-up had significantly higher baseline C-RP concentrations. Women with bilateral OAK had higher C-RP concentrations than women with unilateral OAK (6.65 mg/L +/- 0.56 vs 3.63 mg/L +/- 0.42, P < 0.007). BMI was highly correlated with C-RP (r = 0.58) and obesity was an effect modifier with respect to OAK and C-RP concentrations. When stratified according presence or absence of OAK and obesity (BMI > 30 kg/m2), mean C-RP values were: obesity and OAK, 6.3 +/- 0.4 mg/L; obesity but not OAK, 4.3 mg/L +/- 0.2; no obesity but OAK, 1.7 mg/L +/- 0.8; and neither obesity nor OAK, 1.3 mg/L +/- 0.2 mg/L. These stratum means were significantly different from each other, indicating a higher C-RP with OAK after accounting for obesity.
CONCLUSION: C-RP, as a measure of an acute phase response and inflammation, is highly associated with OAK; however, its high correlation with obesity limits its utility as an exclusive marker for OAK.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479380     DOI: 10.1053/joca.2002.0800

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  38 in total

1.  Early stages of osteoarthritis: the search for sensitive predictors.

Authors:  F A Wollheim
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study.

Authors:  G McGwin; T A Hall; A Xie; C Owsley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  A painful interface between normal aging and disease.

Authors:  Shari Miura Ling; Eleanor M Simonsick; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-06       Impact factor: 6.053

Review 4.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

5.  No association between markers of inflammation and osteoarthritis of the hands and knees.

Authors:  Steven C Vlad; Tuhina Neogi; Piran Aliabadi; João D T Fontes; David T Felson
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

Review 6.  Calcium-Containing Crystals and Osteoarthritis: an Unhealthy Alliance.

Authors:  Richard Conway; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

7.  The value of high-sensitivity C-reactive protein in hand and knee radiographic osteoarthritis: data from the Dong-gu Study.

Authors:  Lihui Wen; Min-Ho Shin; Ji-Hyoun Kang; Yi-Rang Yim; Ji-Eun Kim; Jeong-Won Lee; Kyung-Eun Lee; Dong-Jin Park; Tae-Jong Kim; Yong-Wook Park; Sun-Seog Kweon; Young-Hoon Lee; Yong-Woon Yun; Shin-Seok Lee
Journal:  Clin Rheumatol       Date:  2017-11-21       Impact factor: 2.980

8.  Synovial tissue inflammation in early and late osteoarthritis.

Authors:  M J Benito; D J Veale; O FitzGerald; W B van den Berg; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

9.  Prospective associations of C-reactive protein (CRP) levels and CRP genetic risk scores with risk of total knee and hip replacement for osteoarthritis in a diverse cohort.

Authors:  A H Shadyab; R Terkeltaub; C Kooperberg; A Reiner; C B Eaton; R D Jackson; J L Krok-Schoen; R M Salem; A Z LaCroix
Journal:  Osteoarthritis Cartilage       Date:  2018-05-22       Impact factor: 6.576

10.  Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.

Authors:  V B Kraus; T V Stabler; G Luta; J B Renner; A D Dragomir; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2007-03-28       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.